22 March 2013
Organised by:
SCI's Biotechnology Group in conjunction with the University of Westminster.
University of Westminster
This event is no longer available for registration.
Polyhydroxyalkanoates (PHAs) are natural polymers produced by bacteria under nutrient limiting conditions. These polymers are biodegradable and biocompatible in nature and hence can be used in a variety of applications. These include bulk applications such as packaging, coating materials, adhesives and in medical applications such as tissue engineering wound healing and drug delivery.
In the context of tissue engineering, wound healing and drug delivery. In the context of tissue engineering, due to their varied and mechanical properties and degradation rates PHAs can be used to replace a range of tissue types including one, cartilage, cardiac and skin. Similarly, in the area of drug delivery, the varied properties leads to their potential applications in both short term and long term controlled drug delivery. The talk will describe the various modes of production and purification of these bacterial polymers and their application in hard and soft tissue engineering, wound healing, and controlled drug delivery applications.
SCI accessibility grants are available to support SCI members with disabilities, long term health conditions, those who require a carer, and members who are nursing parents to attend SCI events. Download an application form to apply for a grant.
University of Westminster
University of Westminster,
School of Life Sciences,
115 New Cavendish Street
London W1W 6UW
For a Map click here
SCI Comms Team
Email: Communications@soci.org
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
SCI Members attending this meeting are able to claim CPD points.
An exhibition will take place alongside the conference for companies and related organisations who may wish to exhibit. Please email conferences@soci.org for further information and prices. Spaces are limited and will be allocated on a first-come, first-served basis.